Speratum
Company

Last deal

Amount

Non-equity Assistance

Stage

26.07.2023

Date

3

all rounds

$2.8M

Total amount

date founded

Financing round

General

About Company
Speratum is a biotechnology company that develops targeted molecular therapies for cancer treatment.

Industry

Sector :

Subsector :

founded date

01.03.2014

Number of employees

Company Type

For Profit

Last funding type

Non-equity Assistance

IPO status

Private

Description

Speratum is a biopharmaceutical company that focuses on microRNA-directed oncology therapies. Founded in 2014, the company is dedicated to the development of a patented treatment for pancreatic cancer using tumor suppressive microRNA molecules and nanoparticle-based drug delivery technologies. Speratum is currently in the final stage of preclinical trials for the pancreatic cancer therapy, while expanding its intellectual property portfolio with complementary technologies in the fields of nanotechnology, medical devices, and veterinary medicine. The company's innovative targeted molecular therapies aim to decrease the spread and lead the deregulation of several target factors contributing to the aggressive nature of the disease. Speratum's first therapeutic, a tumor suppressor against pancreatic, ovarian, and other cancers, includes a proprietary RNA interference (RNAi)-inducing mimic of miR-198, a naturally-occurring microRNA involved in the pathogenesis of a number of solid cancers, and a novel delivery system based on Nano-in, their novel polymer that enables the systemic and targeted delivery of nucleic acids both in vitro and in vivo.
Similar Companies
1000
Andes Biotechnologies

Andes Biotechnologies

Andes Biotechnologies is developing drugs for cancer treatment based on oligonucleotide drugs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Santiago, Santiago Metropolitan Region, Chile

total rounds

4
Minerva Biotechnologies

Minerva Biotechnologies

Minerva Biotechnologies develops cancer immunotherapies and stem cell technologies for regenerative medicine.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Waltham, MA, USA

total rounds

7

total raised

$70.02M
Patrys

Patrys

Patrys develops natural human antibody-based therapeutic products for the treatment of cancer and infectious diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Dandenong Rd, Melbourne VIC, Australia
Advanced Proteome Therapeutics

Advanced Proteome Therapeutics

Advanced Proteome Therapeutics is a biotech company that develops novel therapeutics for cancer treatment.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Boston, MA, USA

total rounds

8

total raised

$3.89M

Financials

Funding Rounds
3
3

Number of Funding Rounds

$2.8M

Money Raised

Their latest funding was raised on 26.07.2023. Their latest investor MassChallenge. Their latest round Non-equity Assistance

Date 
Funding Round 
Investors 
Money Raised 
Lead 
MassChallenge

MassChallenge

MassChallenge is a global accelerator that supports startups without taking equity.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Financial Services

Location

Boston, MA, USA

total rounds

1

total raised

$50K

count Of Investments

3143

count Of Exists

173
Carao Ventures

Carao Ventures

Carao Ventures is a venture capital firm that invests in early-stage startups led by founders from Latin America's small and medium markets.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

San José Province, San José, Costa Rica

count Of Investments

36

count Of Exists

1
Carao Ventures

Carao Ventures

Carao Ventures is a venture capital firm that invests in early-stage startups led by founders from Latin America's small and medium markets.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

San José Province, San José, Costa Rica

count Of Investments

36

count Of Exists

1
Co-Investors
Investors
2
2

Number of lead investors

2

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Non-equity Assistance
Yes
Convertible Note, Seed
MassChallenge

MassChallenge

MassChallenge is a global accelerator that supports startups without taking equity.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Financial Services

Location

Boston, MA, USA

total rounds

1

total raised

$50K

count Of Investments

3143

count Of Exists

173
Chaya Pomeranz-Sherman

Chaya Pomeranz-Sherman

Chaya Pomeranz-Sherman is a manager at MassChallenge.

Carao Ventures

Carao Ventures

Carao Ventures is a venture capital firm that invests in early-stage startups led by founders from Latin America's small and medium markets.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

San José Province, San José, Costa Rica

count Of Investments

36

count Of Exists

1
Allan Boruchowicz

Allan Boruchowicz

Allan is Founder and Managing Director at Carao Ventures. He has more than 10 years experience managing private equity investments and has worked and invested in startups in different stages for the last 6 years in Latin America and the US. He founded Carao Ventures in 2012 aiming to offer entrepreneurs in Latin America the same resources and opportunities that entrepreneurs in more developed markets have available to create and advance their startups. At Carao Ventures, Allan leads the investments in Slidebean, BildTEK, Speratum, and Singularities in which he is mentor and Board Member of the companies. Also, he leads the acceleration program for GoPass, Huli, Aerial Robotixs, and Quenti on behalf of the firm. Before founding Carao Ventures, Allan worked for more than 5 years at Mesoamerica Investments, a consulting and private equity management firm in Latin America, at first from the Costa Rican office and afterwards establishing operations of the firm in South America, with office overseeing the region based in Bogotá, Colombia. Prior to working in Mesoamerica, Allan worked for a year managing investments at UBS Wealth Management US. Currently, Allan serves on the Board of Directors of Banco BCT, BCT Puesto de Bolsa, and BCT SAFI; and is Member of the Investment Committee of CRUSA Foundation. Allan has a B.Sc. degree in Business Management with concentration in Finance and Entrepreneurship from Babson College.

current job

Carao Ventures
Carao Ventures

organization founded

1

People

Founders
1
Christian Marin-Muller
Christian Marin-Muller

Christian Marin-Muller

(PhD, Molecular Virology and Microbiology, Baylor College of Medicine; MS, Entrepreneurial Biotechnology, Case Western Reserve University/Weatherhead School of Management; BS, Molecular Biology, Florida Tech) Dr. Marin-Müller has worked in the field of cancer therapeutics for almost a decade, with a specific focus on the use of RNA interference technology and development of nanotechnology-based delivery of therapeutics against solid tumors. He is co-inventor of a therapeutic miRNA treatment that can control a network of biomarkers responsible for aggressive growth and metastasis in pancreatic cancer, and has the potential to completely eliminate tumors both alone and in combination with existing modalities. In addition to his focus on research, Dr. Marin-Müller has also been heavily involved in the biotech industry ecosystem. He has co-founded several biotechnology and service companies, and has worked as a consultant to multiple start-up and governmental organizations, contributing to the development of projects ranging from medical devices to HIV vaccine investigation.

current job

Speratum
Speratum

organization founded

1

Christian Marin-Muller

Employee Profiles
1
Christian Marin-Muller

Christian Marin-Muller

CEO

Activity

Recent News
0